Prevention of appearance of severe Huntington's disease symptoms in the R6/1 mouse model by early administration of 4′,5,7-trihydroxyisoflavone

Journal of Huntington's Disease · Published 2026-07-25 · DOI 10.1177/18796397261472379

Authors (6)

Lidia Gaffke, Estera Rintz, Magdalena Podlacha, Dorota Myślińska, Grzegorz Węgrzyn, Karolina Pierzynowska

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gaffke, L., Rintz, E., Podlacha, M., et al. (2026). Prevention of appearance of severe Huntington's disease symptoms in the R6/1 mouse model by early administration of 4′,5,7-trihydroxyisoflavone. Journal of Huntington's Disease. https://doi.org/10.1177/18796397261472379

Related articles

• Huntington's as a developmental disorder: Molecular and neuropathologic considerations · Journal of Huntington's Disease · 2025 · Cites or is cited by this article · Same journal
• Understanding Huntington’s Disease: Epidemiology, Mechanisms, and Modeling Approaches · CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS · 2026 · Cites or is cited by this article
• Multimodal MRI integrating anti-motion multi-parametric mappings for investigating subcortical nuclei microstructural alterations in Huntington's disease · Journal of Huntington's Disease · 2026 · Same journal
• Effects of computerized cognitive training on functional activity and connectivity in Huntington's disease: A pilot study · Journal of Huntington's Disease · 2025 · Same journal
• Mapping the landscape of caregiver burden in Huntington's Disease: Current evidence and future directions · Journal of Huntington's Disease · 2025 · Same journal
• Phase-targeted auditory stimulation enhances slow-wave activity during sleep in Huntington's disease: A pilot crossover study · Journal of Huntington's Disease · 2026 · Same journal
• Understanding the relationship between patient-reported outcome measures, clinician-rated assessments, and performance-based measures (cognitive tests and device-based estimates) of symptoms and functioning in people with Huntington's disease · Journal of Huntington's Disease · 2025 · Same journal
• Contribution of neuroepigenetics to HD – developmental and aging-related signatures · Journal of Huntington's Disease · 2026 · Same journal
• Dysregulated astrocyte cholesterol synthesis in Huntington's disease: A potential intersection with other cellular dysfunctions · Journal of Huntington's Disease · 2025 · Same journal
• Insights into neurodevelopmental features of Huntington's disease from stem cell-derived models including organoids · Journal of Huntington's Disease · 2025 · Same journal